Retatrutide – 10mg

Retatrutide is a cutting-edge peptide with a triple-agonist mechanism,
activating GLP-1, GIP, and glucagon receptors.
This unique receptor engagement has made it a major focus in research
on weight management, insulin sensitivity, and metabolic regulation.
The 10mg vial offers a smaller dosage option for controlled laboratory studies.

Potential Research Benefits

• Studied for weight reduction and appetite control
• Explored for glucose metabolism & insulin sensitivity
• Supports energy expenditure and lipid research
• Triple receptor activation: GLP-1, GIP & glucagon

Scientific Background

Retatrutide is distinct from dual-agonist peptides due to its additional
glucagon receptor activity.
Research suggests this triple-targeted approach may enhance weight reduction,
glucose control, and lipid metabolism in experimental models.
Its novel receptor profile has made it a leading candidate for
next-generation metabolic research studies.

Product Details

• Compound: Retatrutide
• Form: Lyophilized Powder
• Amount: 10mg per vial
• Purity: ≥99%
• Appearance: White to off-white powder
• Research Use Only: Not for human consumption